Join us in April as we present the Inaugural Perspectives in Digestive Diseases, presented by Intern http://bit.ly/2BNtoER
Join us in April as we present the Inaugural Perspectives in Digestive Diseases, presented by Internal Medicine News & Family Practice News. Explore the latest advances in the treatment and management of gastroenterological diseases.
01/11/2019
Register by 2/18 & Save $100. Join us in March at the 6th Annual Digestive Diseases: New Advances CME/CE conference. The complexity and magnitude of medical advances in the management of digestive diseases make it ever more challenging for clinicians to apply this tremendous amount of information to their practice.
06/01/2018
Earn CME/CE: Optimizing Immunization in IBD, and More:
04/28/2018
See you next year at Perspectives in Digestive Diseases 2019!
04/28/2018
Dr Steven Flamm moderates the final panel discussion at the first annual Perspectives in Digestive Diseases CME/CE conference in Las Vegas.
04/28/2018
Dr Laura Kulik talks about HCC during the panel discussion at Perspectives in Digestive Diseases.
04/28/2018
Dr Bincy Abraham on the podium responds to a question on assessing IBD activity in pregnancy.
04/28/2018
Dr Kimberley Brown responding to audience questions at Perspectives in Digestive Diseases
04/28/2018
Kimberly A. Brown, MD, FAST, FAASLD, AGAF, Chief, Gastroenterology and Hepatology, Associate Medical Director, Henry Ford Transplant Institute, Henry Ford Hospital in Detroit presents on approaches to the patient with abnormal liver tests. Liver tests are a useful noninvasive screening tool for the presence of liver dysfunction. They allow clinicians to assess the severity of liver dysfunction.
04/28/2018
Laura M. Kulik, MD, Professor of Medicine (Gastroenterology and Hepatology), Radiology and Surgery (Organ Transplantation) at Northwestern Feinberg School of Medicine in Chicago presents on hepatocellular carcinoma (HCC) and evaluating liver lesions at Perspectives in Digestive Diseases conference. Surveillance for HCC has improved outcomes due to identification of early HCC. Distinquishing HCC from other malignant lesions is crucial.